上海沪震实业有限公司
扫一扫,手机逛起来
主营:ELISA试剂盒,人ELISA试剂盒,小鼠ELISA试剂盒,大鼠ELISA试剂盒,重组蛋白,金标试剂盒,**组化试剂盒,标准品,单克隆抗体,多克隆抗体,生化试剂,生物培养基,原代细胞,细胞株,实验室耗材,动物血清等产品
021-60345367
您现在的位置:
企业���息
9
  • 注册时间:2015-11-06
  • 联系人:游艳
  • 电话:021-60345367
  • 联系时,请说明仪表网看到的
  • Email:shhzsw01@163.com
在线询价
产品详情

pcDNA5/FRT/TO-TOPO

  • 如果您对该产品感兴趣的话,可以
  • 产品名称:pcDNA5/FRT/TO-TOPO
  • 产品型号:
  • 产品展商:HZbscience
  • 产品文档:无相关文档
  • 发布时间:2017-07-18
  • 在线询价
简单介绍
pcDNA5/FRT/TO-TOPO的各批次质粒菌株发货前均经过严格的多重验证,如存在质量问题,请在收到产品的三个月内通知我司。收到pcDNA5/FRT/TO-TOPO后请短暂离心,取2μl转化至对应感受态中,挑取单克隆重新提取质粒后使用。
产品描述

pcDNA5/FRT/TO-TOPO载体基本信息

载体名称: pcDNA5/FRT/TO-TOPO
质粒类型: 哺乳动物细胞表达载体;cDNA表达载体;定向重组载体;四环素调控载体
高拷贝/低拷贝: 高拷贝
克隆方法: TOPO-TA
启动子: CMVTO
载体大小: 5155 bp
5' 测序引物及序列: CMV Forward: 5’-CGCAAATGGGCGGTAGGCGTG-3’
3' 测序引物及序列: BGH Reverse: 5’-TAGAAGGCACAGTCGAGG-3’
载体标签: 无标签
载体抗性: 氨苄青霉素
筛选标记: 潮霉素(Hygromycin)
克隆菌株: TOP10, DH5α, JM109
宿主细胞(系): Invitrogen公司出品的Flp-In细胞系,293、CV-1、CHO等
备注: pcDNA5/FRT/TO-TOPO载体是cDNA的表达与克隆载体;
CMVTO启动子受四环素调控;
含有FRT位点(重组酶识别位点),与pOG44载体共转染,利用重组酶进行定向重组;
采用TOPO-TA技术,只用5分钟即可将PCR片段连接到载体上去。
产品目录号: K6510-20
稳定性: 瞬表达 或 稳表达
组成型/诱导型: 诱导型
病毒/非病毒: 非病毒

pcDNA5/FRT/TO-TOPO载体质粒图谱和多克隆位点信息

pcDNA5-FRT-TO-TOPO载体图谱



pcDNA5-FRT-TO-TOPO 多克隆位点

pcDNA5-FRT-TO-TOPO 载体特征1
pcDNA5-FRT-TO-TOPO 载体特征2

pcDNA5/FRT/TO-TOPO载体简介

pcDNA5/FRT/TOTOPO 载体简介 pcDNA5/FRT/TO-TOPO is a 5.2 kb expression vector designed to facilitate rapid cloning and tetracycline-regulated expression of PCR products using the Flp-In T-REx System (Catalog no. K6500-01) available from Invitrogen. When cotransfected with the pOG44 Flp recombinase expression plasmid into a Flp-In T-REx mammalian host cell line, the pcDNA5/FRT/TO-TOPO vector containing the PCR product of interest is integrated in a Flp recombinase-dependent manner into the genome. Expression of the gene of interest can then be induced by addition of tetracycline to the culture medium.

pcDNA5/FRT/TO, pcDNA5/FRT/TO-TOPO and pcDNA5/FRT/TO-E are designed for targeted Flp-In integration followed by tetracycline-regulated expression. Each vector contains a FRT site for efficient targeted integration and a hybrid CMV/TetO2 promoter for regulated expression. In addition, pcDNA5/FRT/TO-TOPO and pcDNA5/FRT/TO-E are adapted for TOPO-and Echo Cloning, respectively. TOPO Cloning enables rapid ligation of PCR products into pcDNA5/FRT/TO-TOPO in just five minutes on your bench top. Echo Cloning allows you to quickly shuttle your gene of interest into multiple expression vectors.
The Flp-In T-REx 293 Cell Line is available to save time in expression experiments. This cell line contains pFRT/lacZeo and pcDNA6/TR stably integrated and is tested for its ability to regulate expression . pcDNA5/FRT/TO-TOPO 载体含有以下元件:
 A hybrid human cytomegalovirus (CMV)/TetO2 promoter for high-level, tetracycline-regulated expression of the gene of interest in a wide range of mammalian cells (Andersson et al., 1989; Boshart et al., 1985; Hillen and Berens, 1994; Hillen et al., 1983; Nelson et al., 1987)
 TOPO Cloning site for rapid and efficient cloning of Taq-amplified PCR products
 FLP Recombination Target (FRT) site for Flp recombinase-mediated integration of the vector into the Flp-In T-REx host cell line
 Hygromycin resistance gene for selection of stable cell lines (Gritz and Davies, 1983)

The control plasmid, pcDNA5/FRT/TO/CAT, is included for use as a positive control for transfection and expression in the Flp-In T-REx host cell line of choice. For more information about the Flp-In T-REx System, the pOG44 plasmid, and generation of the Flp-In T-REx host cell line, refer to the Flp-In T-REx Core Kit manual. 杂交 CMV/TetO2 启动子 Expression of your gene of interest from pcDNA5/FRT/TO-TOPO is controlled by the strong human CMV immediate early enhancer/promoter (Andersson et al., 1989; Boshart et al., 1985; Nelson et al., 1987) into which 2 copies of the tet operator 2 (TetO2) sequence have been inserted in tandem. Insertion of these TetO2 sequences into the CMV promoter confers regulation by tetracycline to the promoter.
The TetO2 sequences consist of 2 copies of the 19 nucleotide sequence, 5′-TCCCTATCAGTGATAGAGA-3′ separated by a 2 base pair spacer (Hillen and Berens, 1994; Hillen et al., 1983). Each 19 nucleotide TetO2 sequence serves as the binding site for 2 molecules of the Tet repressor. For more information about the mechanism of tetracycline regulation in the Flp-In T-REx System, refer to the Flp-In T-REx Core Kit manual. FRT 位点 The pcDNA5/FRT/TO-TOPO vector contains a single FRT site immediately upstream of the hygromycin resistance gene for Flp recombinase-mediated integration and selection of the pcDNA5/FRT/TO-TOPO construct following cotransfection of the vector (with pOG44) into a Flp-In T-REx mammalian host cell line. The FRT site serves as both the recognition and cleavage site for the Flp recombinase and allows recombination to occur immediately adjacent to the hygromycin resistance gene. The Flp recombinase is expressed from the pOG44 plasmid. For more information about the FRT site and recombination, see below. For more information about pOG44, refer to the pOG44 manual or the Flp-In T-REx Core Kit manual.

for Flp recombinase and has been well-characterized (Gronostajski and Sadowski, 1985; Jayaram, 1985; Sauer, 1994; Senecoff et al., 1985). The minimal FRT site consists of a 34 bp sequence containing two 13 bp imperfect inverted repeats separated by an 8 bp spacer that includes an Xba I restriction site. An additional 13 bp repeat is found in most FRT sites, but is not required for cleavage (Andrews et al., 1985). While Flp recombinase binds to all three of the 13 bp repeats, strand cleavage actually occurs at the boundaries of the 8 bp spacer region (Andrews et al., 1985; Senecoff et al., 1985).

The hygromycin resistance gene in pcDNA5/FRT/TO-TOPO lacks a promoter and an ATG initiation codon; therefore, transfection of the pcDNA5/FRT/TO-TOPO plasmid alone into mammalian host cells will not confer hygromycin resistance to the cells. The SV40 promoter and ATG initiation codon required for expression of the hygromycin resistance gene are integrated into the genome (in the Flp-In T-REx host cell line) and are only brought into the correct proximity and frame with the hygromycin resistance gene through Flp recombinase-mediated integration of pcDNA5/FRT/TO-TOPO at the FRT site. Flp 重组酶介导的DNA重组 In the Flp-InT-RExSystem, integration of your pcDNA5/FRT/TO-TOPO expression construct into the genome occurs via Flp recombinase-mediated intermolecular DNA recombination. The hallmarks of Flp-mediated recombination are listed below. Recombination occurs between specific FRT sites on the interacting DNA molecules Recombination is conservative and requires no DNA synthesis; the FRT sites are preserved following recombination and there is minimal opportunity for introduction of mutations at the recombination site Strand exchange requires only the small 34 bp minimal FRT site TOPO克隆工作原理 The plasmid vector, pcDNA5/FRT/TO-TOPO, is supplied linearized with:
 Single 3′ thymidine (T) overhangs for TA Cloning
 Topoisomerase covalently bound to the vector (this is referred to as “activated” vector) Taq polymerase has a nontemplate-dependent terminal transferase activity that adds a single deoxyadenosine (A) to the 3′ ends of PCR products. The linearized vector supplied in this kit has single, overhanging 3′ deoxythymidine (T) residues. This allows PCR inserts to ligate efficiently with the vector.
Topoisomerase I from Vaccinia virus binds to duplex DNA at specific sites and cleaves the phosphodiester backbone after 5′-CCCTT in one strand (Shuman, 1991). The energy from the broken phosphodiester backbone is conserved by formation of a covalent bond between the 3′ phosphate of the cleaved strand and a tyrosyl residue (Tyr-274) of topoisomerase I. The phospho-tyrosyl bond between the DNA and enzyme can subsequently be attacked by the 5′ hydroxyl of the original cleaved strand, reversing the reaction and releasing topoisomerase (Shuman, 1994). TOPO Cloning exploits this reaction to efficiently clone PCR products . 
TOPO克隆技术原理



pcDNA5/FRT/TO-TOPO载体表达实验流程图 
pcDNA5-FRT-TO-TOPO 使用流程



pcDNA5/FRT/TO-TOPO载体序列

hz-8210R FAM91A1  FAM91A1蛋白抗体
hz-4147R ODF2/Cenexin1  精子尾部结构蛋白抗体
hz-8211R FAM84B/BCMP101  乳腺癌膜相关蛋白101抗体
hz-8212R TEF4/TEA domain family mhzber 2  转录增强因子TEF4抗体
hz-8213R FAM113A  FAM113A蛋白抗体
hz-8214R FAM21C  FAM21C蛋白抗体
hz-8215R FAM13C1  FAM13C1蛋白抗体
hz-8216R FAM161A  FAM161A蛋白抗体
hz-8217R FAM59B  FAM59B蛋白抗体
hz-8218R FAM59A  FAM59A蛋白抗体
hz-8219R FAM150A  FAM150A蛋白抗体
hz-8220R FAM151A  FAM151A蛋白抗体
hz-5530R phospho-ODF2(Ser796)  磷酸化精子尾部结构蛋白抗体
hz-8221R FAM153B  FAM153B蛋白抗体
hz-8222R FAM154A  FAM154A蛋白抗体
hz-8223R FAM155A  FAM155A蛋白抗体
hz-8224R FAM156A/TMhz2  跨膜蛋白29抗体
hz-8225R FAM160B1  FAM160B1蛋白抗体
hz-8226R FAM161B  FAM161B蛋白抗体
hz-8227R FAM164B  FAM164B蛋白抗体

关于我们| 易展动态| 易展荣誉| 易展服务| 易家文化| 英才集结号| 社会责任| 联系我们

备案号:粤ICP备11010883号| 公安机关备案号:44040202000312| 版权问题及信息删除: 0756-2183610  QQ: 服务QQ

Copyright?2004-2017  珠海市金信桥网络科技有限公司 版权所有

行业网站百强奖牌 搜索营销*有价值奖 中小企业电子商务**服务商
以上信息由企业自行提供,信息内容的真实性、准确性和合法性由相关企业负责,易展仪表展览网对此不承担任何保证责任。

沪公网安备 31011702004356号